Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pharmacokinetics of Bisoprolol

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: FUKUMOTO, Kyoko (Niigata University of Pharmacy and Applied Life Sciences, Department of Clinical Pharmacokinetics, Niigata, Japan)
  • Co-author(s): Yokota, Yoko (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
    Nakamura, Masahiko (Internal Medicine, Yamanashi Prefectural Central Hospital, Kofu, Japan)
    Pitchaimani, Vigneshwaran (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
    Harima, Meilei (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
    Watanabe, Kenichi (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
    Ueno, Kazuyuki (Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan)
  • Abstract:

    I. Background

    Bisoprolol is a selective beta-blocker has been widely prescribed for the treatment of cardiovascular disease. It is eliminated by renal and non-renal routes. Therefore, clinical conditions as renal or hepatic dysfunction may alter bisoprolol metabolism or excretion. However, the pharmacokinetics of bisoprolol has not been clarified ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses